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Malaria is one of the world’s deadliest infectious diseases, 
with over 200 million infections and hundreds of thousands of 
deaths annually. The malaria parasite Plasmodium berghei is a 
complex protozoan organism that requires two hosts: the human, 
site of asexual reproduction, and the Anopheles mosquito, where 
sexual reproduction occurs. My research project seeks to 
understand the antioxidant defense mechanisms P. berghei
employs to withstand the hostile extracellular environment of 
the Anopheles mosquito vector through upregulation of 1-
Cysteine Peroxiredoxin (1-CPrx). When activated, defense gene 
1-CPrx counteracts reactive oxygen species (ROS) released by the 
mosquito as an immune response. Our goal is to determine the 
mechanisms that allow the parasite to sense an environmental 
change and respond through upregulation of 1-CPrx. We 
hypothesize the activation of 1-CPrx promoter is driven by an 
antioxidant response element (ARE), which upregulates the 
defense gene. 
To effectively bridge the gap from the intermediate human host 
to the mosquito, Plasmodium must re-organize its cell biology to 
adapt to the unique cellular conditions in each host. Migration 
through the midgut of the mosquito is a dangerous feat 
for Plasmodium, openly exposed to the mosquito’s defense 
mechanisms; immersed in the mosquito’s blood meal, 
Plasmodium faces threat of digestion and risk of damage by 
cytotoxic reactive oxygen (ROS) and reactive nitrogen species 
(RNS). To counteract the mosquito’s immune response, 
Plasmodium upregulates specific antioxidant defense genes (Fig. 
1). The Kanzok lab determined that one of these antioxidant 
genes, 1-Cysteine Peroxiredoxin (1-CPrx), is strongly upregulated 
by the parasite to combat exposure to ROS in the mosquito 
midgut (Turturice et al 2013). Characterization of antioxidant 
defense genes is of importance to us because they serve as 
attractive targets for the development of transmission blocking 
strategies to combat malaria. My objective is to determine the 
location of the ARE in the promoter of 1-CPrx using a “promoter-
bashing” approach, established by former lab student Cecile 
Swift. I will utilize a series of luciferase reporter constructs and 
transfect them into P. berghei to study the 1-CPrx promoter. 
Using this method, I will map the promoter of 1-CPrx to find the 
location of the ARE and characterize the first inducible promoter 
of the malaria parasite Plasmodium (Fig. 2).
Using the transfection protocol, pilot data 
for 2.4kb and 1.0kb 1-CPrx promoter 
fragments with comparable luciferase signals 
were generated by Swift. Luminescence of the 
1.0kb fragment indicates the presence of the 
minimal promoter region. From Swift’s pilot 
data, I have generated numerous plasmids 
containing the 0.5kb and 1.0kb 1-CPrx 
promoter fragments through bacterial 
transformation to begin the process of locating 
the ARE within the 1.0kb fragment. To ensure 
the presence of the 1-CPrx gene of interest, 
DNA samples were then subjected to restriction 
digests using restriction enzyme KPNI, followed 
by analytical gel electrophoresis of the digested 
sample to confirm the bacteria had been 
successfully transformed with the 1-CPrx 
promoter fragments (Fig. 3).
My long-term goals will encompass a) removal of the putative TF-
binding site from the parasite genome to determine whether 1-CPrx 
expression is negatively affected and results in increased sensitivity to 
ROS in the malaria parasite, b) using the TF-binding site as bait to 
identify the transcription factor that binds to the TF-binding site and 
regulates 1-CPrx expression, c) using computational methods to 
screen the Plasmodium genome for presence of newly identified TF-
binding site(s) and TFs. Localization of the ARE could be used to 
determine the transcription factor that leads to its activation and will 





Turturice BA, et al PLoS Pathog. 2013 
Jan;9(1):e1003136. doi: 
10.1371/journal.ppat.1003136. Epub
2013 Jan 31. PMID: 23382676; 
PMCID: PMC3561267.
METHODS
To generate results for my research project, I must create my 
“molecular toolbox,” which involves (1) generation of excess 
insert DNA (K fragments, removed from plain PDLC vector); (2) 
generation of vector DNA—PDLC 0.5ΔK and PDLC 1.0 ΔK; (3) 
practice handling, infecting, and exsanguinating mice to be 
transfected with target DNA.
RESULTS
Using the purified 1-CPrx promoter fragments, luciferase reporter 
plasmids will be generated, followed by transfection of P. berghei with 
reporter plasmids and subsequent quantification of the 1-CPrx 
promoter in the luciferase assay. The reporter plasmid is transfected 
into the parasite via electroporation, then the mouse is infected. 
Activation of 1-CPrx leads to the subsequent activation of 
the luc gene, generating luminescence; luminescence is quantified 
using a luminometer relative to a control group (a Renilla luc protein 
coupled to a control promoter). A truncated 1-CPrx gene containing 
the promoter should yield a strong luminescence signal. Currently, I 
have completed mouse training in the ACF and am learning how to 
infect mice with parasites via intraperitoneal and tail-vein injections, 
perform tail snips for blood smears, determine parasitemia, and 
exsanguinate infected mice to obtain parasites. Once I have gained 
more experience handling mice, I will transfect mice with my luciferase 
reporter constructs. I will also use computational methods to analyze 
the 1-CPrx promoter for potential transcription factor binding sites. 
The goal is to determine the location of the ARE by generating 
systematically smaller fragments and analyze resulting luminescence. 
A fragment exhibiting no luminescence implies the inducible region is 
no longer present. Once identified, I will screen 
the Plasmodium genome for additional ARE sites on other genes.
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Figure 1: Plasmodium’s Regulation of Oxidative Stress Response via 
1-CPrx Upregulation (Swift et al., in prep)
Figure 2: Promoter contains Antioxidant Response 
Elements (Swift et al., in prep)
Figure 3: Transformation of Bacteria 
and DNA Extraction
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